Le Lézard
Classified in: Health
Subjects: WOM, MAT

vConfidence Launches a Full-On Rebrand with Continued Commitment to Vaginal Health Education & Methods


CHARLOTTE, N.C., Aug. 17, 2018 /PRNewswire/ -- Stress incontinence. Vaginal dryness. OAB. Those are just a select few of any number of challenging, oftentimes painful vaginal health conditions that impact millions of women every year. What's even more challenging for the mothers, daughters, sisters, women in our lives?

Women rarely discuss these conditions ? or the solutions to them ? openly.

vConfidence wants to change that for today's woman ? and for generations to come.

Starting today, the Charlotte-based company launches a full-on, rebranding commitment across web design, content strategy, and social media driven by an important tagline that says it all ? Why be PC when you can VC?

The effort is not only about continuing to share the company's well-established reputation and success, but also engaging a new demographic of younger women impacted by vaginal health conditions following childbirth or early onset menopause.

"These health conditions aren't changing ? but women are," says Dr. Tess Mauricio, Board Certified Dermatologist. "Today, women are more empowered, in-control, active participants when it comes to their bodies and their health than ever before; we want vConfidence to serve as not only a brand and treatment solution, but also a health-driven, thought leader for these busy, active, and empowered women."

Despite the rebrand, vConfidence's treatment options, providers, and data-driven approach will not be changing. In 2017, vConfidence solutions were available in over 150 locations across the U.S. and Canada through vConfidence certified doctors - industry-leading gynecologists, obstetricians, dermatologists, and plastic surgeons. Each is equipped with a cloud-enabled approach to deliver an innovative, minimally invasive, virtually painless procedures. vConfidence utilizes only the safest procedures on the market; the company continues to commit to the extra mile ensuring all practitioners are properly trained and up-to-date to deliver safe and successful outcomes that change how a woman experiences life.

New service and product offerings will be available across the U.S. and Canada in Fall 2018.

vConfidence's leadership team does hope the rebrand inspires fresh change in one important part of life ? a woman's confidence.

"Our team at vConfidence wants these treatment options to make a real, game-changing difference in the quality of a woman's life and her sense of self," says Brittani Phillips, vConfidence's creator. "If this rebrand can help educate on those options AND then spark important, PC to VC conversations that inspire greater confidence, then we've created long-term change that trickles down through generations of women."

ABOUT VCONFIDENCE: vConfidence is the modern women's partner in vaginal health empowerment. Our certified doctors are leading gynecologists, dermatologists, and plastic surgeons who deliver our innovative, non-invasive, energy-based procedures to resolve vaginal health challenges. We research, evaluate, and deliver revolutionary solutions that enhance a woman's quality of life with minimal downtime and successful, long-lasting results. For more information, please visit vconfidence.com.


SOURCE vConfidence


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: